Ausgabe 1/2003
Inhalt (6 Artikel)
Current Opinion
Patients’ Understanding of Risk Associated with Medication Use
Dianne C. Berry, D.K. Raynor, Peter Knapp, Elisabetta Bersellini
Leading Article
Cytochrome P450 Drug Interactions Within the HMG-CoA Reductase Inhibitor Class
Jennifer Martin, Henry Krum
Review Article
Benefit-Risk Assessment of Infliximab in the Treatment of Rheumatoid Arthritis
Ted R. Mikuls, Larry W. Moreland
Original Research Article
Adverse Events Associated with Rofecoxib Therapy
Bernard Bannwarth, Richard Trèves, Liana Euller-Ziegler, Denis Rolland, Philippe Ravaud, Maxime Dougados
Original Research Article
Benefits and Risks of Pharmacotherapy for Dysthymia
Maurício S. De Lima, Matthew Hotopf